Market News

Akebia Therapeutics Inc. (AKBA)’s Financial Results Comparing With Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)

Akebia Therapeutics Inc. (NASDAQ:AKBA) and Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income […]

Reviewing Kamada Ltd. (KMDA)’s and ArQule Inc. (NASDAQ:ARQL)’s results

Kamada Ltd. (NASDAQ:KMDA) and ArQule Inc. (NASDAQ:ARQL) compete against each other in the Biotechnology sector. We will compare them and contrast their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kamada Ltd. 5 1.71 […]

Contrasting of Cellular Biomedicine Group Inc. (CBMG) and Oncolytics Biotech Inc. (NASDAQ:ONCY)

We will be contrasting the differences between Cellular Biomedicine Group Inc. (NASDAQ:CBMG) and Oncolytics Biotech Inc. (NASDAQ:ONCY) as far as dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership are concerned. The two businesses are rivals in the Biotechnology industry. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]

Comparison of Axovant Gene Therapies Ltd. (AXGT) and Genprex Inc. (NASDAQ:GNPX)

This is a contrast between Axovant Gene Therapies Ltd. (NASDAQ:AXGT) and Genprex Inc. (NASDAQ:GNPX) based on their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing AC Immune SA (ACIU)’s and Neuralstem Inc. (NASDAQ:CUR)’s results

We will be contrasting the differences between AC Immune SA (NASDAQ:ACIU) and Neuralstem Inc. (NASDAQ:CUR) as far as dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing Kamada Ltd. (KMDA)’s and Urovant Sciences Ltd. (NASDAQ:UROV)’s results

This is a contrast between Kamada Ltd. (NASDAQ:KMDA) and Urovant Sciences Ltd. (NASDAQ:UROV) based on their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing Kala Pharmaceuticals Inc. (KALA)’s and Unum Therapeutics Inc. (NASDAQ:UMRX)’s results

As Biotechnology companies, Kala Pharmaceuticals Inc. (NASDAQ:KALA) and Unum Therapeutics Inc. (NASDAQ:UMRX) are our subject to contrast. And more specifically their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kala Pharmaceuticals Inc. 4 -0.04 […]

Reviewing Safe Bulkers Inc. (SB)’s and Hermitage Offshore Services Ltd. (NYSE:PSV)’s results

Both Safe Bulkers Inc. (NYSE:SB) and Hermitage Offshore Services Ltd. (NYSE:PSV) compete on a level playing field in the Shipping industry. We will evaluate their performance with regards to dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]